Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-008601
Filing Date
2023-01-31
Accepted
2023-01-31 16:09:58
Documents
1
Period of Report
2023-01-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm234943-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm234943-3_4seq1.xml 4 4308
  Complete submission text file 0001104659-23-008601.txt   6011
Mailing Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472 781-577-5300
Eloxx Pharmaceuticals, Inc. (Issuer) CIK: 0001035354 (see all company filings)

EIN.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address OPKO HEALTH, INC. 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address
Rubin Steven D (Reporting) CIK: 0001381874 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31326 | Film No.: 23572656